896746-85-3

Upstream product

• 896746-83-1 (R)-4-(2-benzoyl-phenylcarbamoyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 896746-84-2 (R)-3-hydroxymethyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 1140908-16-2 (R,E)-methyl4-(2-(3((4-chloro-2-(trifluoromethyl)phenylcarbamoyloxy)methyl)-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)acetamido)but-2-enoate 
• 1012860-24-0 {(3R)-1-[2-(allylamino)-2-oxoethyl]2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl}methyl[4-chloro-2-(trifluoromethyl)phenyl]carbamate 
• 1012860-26-2 N-allyl-2-[(3R)-3-(hydroxymethyl)-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-1-yl]acetamide 
• 1012860-22-8 N-allyl-2-[(3R)-3-({[tert-butyl(dimethyl)silyl]oxy}methyl)-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-1-yl]acetamide 
• 1623752-72-6 1-[2-((5S)-3-bromo-4,5-dihydroisoxazol-5-yl)ethyl]-3(3R)-(tert-butyldimethylsilyloxymethyl)-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one 
• 1623752-71-5 1-[2-((5R)-3-bromo-4,5-dihydroisoxazol-5-yl)ethyl]-3-(3R)-(tert-butyldimethylsilyloxymethyl)-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one 
• 1623752-70-4 3-(R)-(tert-butyldimethylsilyloxymethyl)-1-hex-5-enyl-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one 
• 1623752-69-1 3-(R)-(tert-butyldimethylsilyloxymethyl)-1-pent-4-enyl-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one 
• 1623752-73-7 1-[3-((5R)-3-bromo-4,5-dihydroisoxazol-5-yl)propyl]-3-(3R)-(tert-butyldimethylsilyloxymethyl)-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one 
• 1623752-74-8 1-[3-((5S)-3-bromo-4,5-dihydroisoxazol-5-yl)propyl]-3-(3R)-(tert-butyldimethylsilyloxymethyl)-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one 
• 1623752-68-0 1-but-3-enyl-3-(R)-(tert-butyldimethylsilyloxymethyl)-5-phenyl-1,3-dihydrobenzo[e][1,4]diazepin-2-one 
• 896746-98-8 4-semicarbazone-3(S)-[2-(2-oxo-5-phenyl-3(R)-(4-chloro-2-trifluoromethylphenylcarbamoyloxymethyl)-2,3-dihydro-benzo[e][1,4]diazepin-1-yl)acetylamino]butyric acid tert-butyl ester 
• 896746-96-6 4-semicarbazone-3(S)-[2-(2-oxo-5-phenyl-3(R)-(2-bromo-4,6-difluorophenylcarbamoyloxymethyl)-2,3-dihydro-benzo[e][1,4]diazepin-1-yl)acetylamino]butyric acid tert-butyl ester 
• 896746-91-1 4-semicarbazone-3(S)-[2-(2-oxo-5-phenyl-3(R)-(1-naphthylcarbamoyloxymethyl)-2,3-dihydro-benzo[e][1,4]diazepin-1-yl)acetylamino]butyric acid tert-butyl ester 

Relevant academic research and scientific papers

NMR characterization and conformational analysis of a potent papain-family cathepsin L-like cysteine protease inhibitor with different behaviour in polar and apolar media

We recently reported the synthesis, of a potent papain-family cathepsin L-like cysteine protease inhibitor, as new lead compound for the development of new drugs that can be used as antiprotozoal agents. The investigation of its conformational profile is

Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors

This paper describes the synthesis of a new class of peptidomimetic cysteine protease inhibitors based on a 1,4-benzodiazepine scaffold and on an electrophilic vinyl sulfone moiety. The former was introduced internally to a peptide sequence that mimics th

Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents

The synthesis of a new class of peptidomimetics 1a-j, based on a 1,4-benzodiazepine scaffold and on a C-terminal aspartyl aldehyde building block, is described. Compounds 1a-j provided significant inhibitory activity against falcipains 2A and 2B (FP-2A an